Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
- Resource Type
- Article
- Authors
- Guttman, Mark; Raymond, Lynn; Mendis, Tilak; Suchowersky, Oksana; Corey-Bloom, Jody; Geschwind, Michael D; Marshall, Frederick J; Marder, Karen S; Nance, Martha; Racette, Brad; Bang, Jee; Segro, Victoria; McDonell, Katherine; Kamholz, John; LeDoux, Mark S; Sanchez-Ramos, Juan; DeMichele, Giuseppe; Mariotti, Caterina; Squitieri, Ferdinando; Soliveri, Paola; Cortelli, Pietro; Muñoz García, José Esteban; Kulisevsky Bojarski, Jaime; López-Sendón Moreno, José Luis; Berganzo Corrales, Koldo; Cubo, Esther; García Moreno, José Manuel; Orth, Michael; Priller, Josef; Saft, Carsten; Weindl, Adolf; Winkler, Juergen; Craufurd, David; Miedzybrodzka, Zofia; Rickards, Hugh; Davies, Rhys Richard; Lahiri, Nayana; Ruddy, Deborah; Komati, Suresh K; Quarrell, Oliver William John; Correira Guedes, Leonor; Roos, Raymund A C; Zalyalova, Zuleykha; Illarioshkin, Sergey; Gustov, Aleksandr; Klempir, Jiri; Reilmann, Ralf ; Anderson, Karen E; Feigin, Andrew; Tabrizi, Sarah J; Leavitt, Blair R; Stout, Julie C; Piccini, Paola; Schubert, Robin; Loupe, Pippa; Wickenberg, Anna ; Borowsky, Beth ; Rynkowski, Gail; Volkinshtein, Rita; Li, Thomas; Savola, Juha-Matti ; Hayden, Michael ; Gordon, Mark Forrest
- Source
- In The Lancet Neurology March 2024 23(3):243-255
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1474-4422